SPP1–M2 Macrophage Crosstalk in ESCC
2026-09-02
A 2024 British Journal of Cancer study identifies SPP1 as an active driver of oesophageal squamous cell carcinoma progression rather than merely a prognostic marker. The work connects SPP1 from ESCC cells to CD44/PI3K/AKT-dependent macrophage recruitment and M2-like polarization, with downstream VEGFA and IL6 supporting tumour growth.
Difloxacin HCl: Applied Assays and Workflow Guide
2026-09-01
Difloxacin HCl supports two complementary research workflows: phenotypic antimicrobial susceptibility testing and exploratory multidrug resistance reversal studies. This guide connects DNA gyrase–based bacterial assays with carefully controlled neuroblastoma experiments while distinguishing established product applications from mechanistic hypotheses inspired by mitotic checkpoint research.
HyperScribe™ Poly (A) Tailing Kit for mRNA Workflows
2026-09-01
Build more reliable post-transcriptional RNA workflows for transfection experiments, micro-injection, and protein-expression assays. The HyperScribe™ Poly (A) Tailing Kit combines E. coli Poly (A) Polymerase with ATP and MnCl2 to support consistent tailing of HyperScribe™ T7-generated transcripts while leaving room for sequence, cap, and nucleoside-modification optimization.
BML-277 for Chk2 DNA Damage Response Studies
2026-08-31
BML-277 provides a reversible, ATP-competitive way to interrogate Chk2 signaling across biochemical assays, irradiated T-cell models, and emerging nuclear cGAS studies. Its nanomolar enzyme potency and micromolar cellular response range support dose-separation experiments that distinguish direct kinase inhibition from downstream radiobiological effects.
How Dual-Action Inhibitors Reprogram p38α Dephosphorylation
2026-08-30
The reference preprint identifies a dual-action mode in which selected kinase inhibitors both occupy the p38α active site and accelerate WIP1-mediated removal of the activation-loop phosphate. Structural data explain this effect as a conformational mechanism, suggesting that kinase inhibitor design can influence signal termination as well as catalytic activity.
Alcian Blue & Nuclear Fast Red Staining Kit pH2.5
2026-08-29
A practical guide to using dual-color acid mucin staining for chondrogenic differentiation, mucopolysaccharide-rich tissues, and clearer cellular morphology. The workflow combines Alcian Blue signal detection with Nuclear Fast Red contrast while addressing small-sample handling, controls, and troubleshooting.
Thiamet G for Reliable Cell Assays
2026-08-29
A scenario-based guide to using Thiamet G (SKU B2048) as an O-GlcNAcase inhibitor in viability, cytotoxicity, tauopathy, leukemia, and trophoblast workflows. It connects product specifications with practical controls for stock preparation, assay interpretation, and vendor selection.
AhR–RBX1/HSF1 Signaling in Acute Pancreatitis
2026-08-28
Fang and colleagues identify aryl hydrocarbon receptor signaling as a regulator of pancreatic tight-junction injury in severe acute pancreatitis, linking AhR to HSF1, RBX1-dependent ubiquitination, and macrophage polarization. The study combines a cerulein/LPS mouse model with primary acinar-cell and macrophage experiments, while pharmacological inhibition with triptolide supports—but does not by itself prove—the proposed pathway.
DiscoveryProbe™ FDA-Approved Drug Library for Stress Biology
2026-08-28
The DiscoveryProbe FDA-approved Drug Library (L1021) enables mechanism-first screening of proteotoxic and oxidative-stress responses. Grounded in the CRTC-CREB study in Drosophila, this guide shows how to connect phenotypic hits with ROS, JNK, transcriptional, and proteostasis readouts.
Wnt Agonist 1: From β-Catenin to Translation
2026-08-27
A translational perspective on Wnt agonist 1 (BML-284), linking controlled β-catenin–TCF activation with differentiation research and the Wnt/NR2F2/GPX4 chemoresistance axis described in lung cancer brain metastasis.
nor-NOHA Acetate in Immunometabolism
2026-08-27
Use nor-NOHA acetate to dissect how arginase-controlled arginine flux influences tumor-cell behavior, nitric oxide biology, and immune assays. This workflow pairs target-engagement measurements with CD36–lipid signaling experiments without overstating an unproven connection between the two metabolic pathways.
DiD for Membrane Tracking in Diabetic Periodontitis
2026-08-26
DiD (DiDC 18 (5)) transforms cell membrane staining into a spatial assay for macrophage migration, adhesion, and tissue interactions in diabetic periodontitis research. This article explains how to pair the red fluorescent membrane probe with ROS, inflammatory, and tissue-repair readouts without confusing membrane location with mitochondrial mechanism.
GW 4869 in Exosome–Osteogenesis Workflows
2026-08-26
GW 4869 provides a practical perturbation strategy for testing whether lithium-engineered BMSC exosomes, rather than soluble signals alone, drive Wnt10a-dependent osteogenesis. This workflow combines neutral sphingomyelinase inhibition with vesicle characterization, cargo analysis, and functional bone-formation assays.
CK2 and ERK8 Inhibitor: Assay Strategy
2026-08-25
Explore how the CK2 and ERK8 inhibitor can function as a small molecule inhibitor for separating kinase-dependent signaling from direct condensate effects. This article translates SARS-CoV-2 nucleocapsid phase-separation research into a rigorous, research-use-only assay framework.
Rosiglitazone Workflows for Adipose Metabolism
2026-08-25
Build cleaner adipocyte experiments with Rosiglitazone (Brl-49653) by separating PPARγ-driven differentiation, insulin sensitivity modulation, and beige-fat thermogenesis. This workflow pairs a defined chemical perturbation with SETD7-focused assays to improve pathway resolution and troubleshooting.
466 records 7/32 page Previous Next First page 上5页 678910 下5页 Last page